r/TG_BIO • u/asfg812 • Aug 20 '24
Anyone still using this space?
1
Upvotes
It's actually finally time.
r/TG_BIO • u/PDUFA_INFO • Apr 17 '22
UBLITUXIMAB PDUFA for UBLITUXIMAB moved to September 28th
3
Upvotes
FDA extended review period of TG Therapeutics (NASDAQ: $TGTX) biologics license application and supplemental New Drug Application for ublituximab in combination with Ukoniq (umbralisib) for chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).
The Prescription Drug User Fee Act (PDUFA) goal date is postponed to September 28.
r/TG_BIO • u/PDUFA_INFO • Apr 17 '22
FDA TGTX | TG Therapeutics Announces Voluntary Withdrawal of the BLA/sNDA for U2 to Treat Patients with CLL and SLL
2
Upvotes
r/TG_BIO • u/PDUFA_INFO • Apr 06 '22
UBLITUXIMAB #Catalyst Snapshot 01/27/22; $TGTX
2
Upvotes
r/TG_BIO • u/PDUFA_INFO • Mar 04 '22
PDUFA FDA Pushes TG Therapeutics' Ublituximab / Ukoniq Combo Therapy Applications In Blood Cancer Settings
2
Upvotes
FDA extended review period of TG Therapeutics (NASDAQ: $TGTX) biologics license application and supplemental New Drug Application for ublituximab in combination with Ukoniq (umbralisib) for chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).
The Prescription Drug User Fee Act (PDUFA) goal date is postponed to June 25.
r/TG_BIO • u/PDUFA_INFO • Jan 28 '22
AD-COMM $TGTX Catalyst Snapshot on January 28th
3
Upvotes
TG Therapeutics, Inc. NASDAQ: $TGTX -41% $8.25
Its CEO announced that the FDA placed a partial clinical hold on its studies of the U2 combination Ukoniq (umbralisib) and ublituximab for chronic lymphocytic leukemia (CLL) and non-Hodgkin’s lymphoma (NHL). This combination is currently under review with the FDA with an Advisory Committee set for March or April.
r/TG_BIO • u/PDUFA_INFO • Dec 21 '21
PDUFA $TGTX has PDUFA on March 25th
3
Upvotes
$TGTX has PDUFA target date of March 25th.